193 related articles for article (PubMed ID: 15705989)
1. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old.
Straub DA; Minocchieri S; Moeller A; Hamacher J; Wildhaber JH
Chest; 2005 Feb; 127(2):509-14. PubMed ID: 15705989
[TBL] [Abstract][Full Text] [Related]
2. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
3. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.
Bisgaard H; Loland L; Oj JA
Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811
[TBL] [Abstract][Full Text] [Related]
4. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
5. Effects of montelukast on symptoms and eNO in children with mild to moderate asthma.
Lee MY; Lai YS; Yang KD; Chen CJ; Hung CH
Pediatr Int; 2005 Dec; 47(6):622-6. PubMed ID: 16354213
[TBL] [Abstract][Full Text] [Related]
6. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
[TBL] [Abstract][Full Text] [Related]
7. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
9. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study).
Nieto A; Pamies R; Oliver F; Medina A; Caballero L; Mazon A
Respir Med; 2006 Jul; 100(7):1180-5. PubMed ID: 16330196
[TBL] [Abstract][Full Text] [Related]
10. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Buchvald F; Bisgaard H
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
[TBL] [Abstract][Full Text] [Related]
12. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR
Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563
[TBL] [Abstract][Full Text] [Related]
13. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma.
Straub DA; Moeller A; Minocchieri S; Hamacher J; Sennhauser FH; Hall GL; Wildhaber JH
Eur Respir J; 2005 Feb; 25(2):289-94. PubMed ID: 15684293
[TBL] [Abstract][Full Text] [Related]
14. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G
Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221
[TBL] [Abstract][Full Text] [Related]
15. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.
Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):767-74. PubMed ID: 17201236
[TBL] [Abstract][Full Text] [Related]
16. Montelukast in childhood asthma.
Mehta PN
Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
[No Abstract] [Full Text] [Related]
17. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
[TBL] [Abstract][Full Text] [Related]
18. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
19. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
20. Montelukast in childhood asthma: what is the evidence for its use?
Amlani S; McIvor RA
Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
